About Precision Diagnostics
Precision Diagnostics is a Healthcare company based in San Diego (United States) founded in 2011, and was acquired by BelHealth Investment Partners in May 2014. Quantitative urine drug testing is provided for patient monitoring. The company has 358 employees. Precision Diagnostics offers products and services including VerifID, NextGen, UpNEXT, and DDI. Its focus areas include Life Sciences, Toxicology and In Vitro Diagnotic Tests. Its competitors include IntegenX, Ameritox and Abreos Biosciences; 2 of its 3 listed competitors have raised funding.
Company details
Precision Diagnostics, formerly known as Precision Toxicology, provides quantitative confirmation urine drug testing services that allow physicians to monitor patients on chronic opioid therapy. Its test panel technology tests for various prescription medications, as well as illicit drugs. Services include NextGen Precision Testing platform; Precision TBM, a Toxicology Benefit Management program to better manage the clinical drug testing benefit; SOF-Adhere , to detect the amount of the sofosbuvir metabolite in a patients urine sample and Oral fluid testing. It is a BelHealth portfolio company since April 2014.
- Headquarters San Diego, United States
- Employees 358
- Stage Acquired
- SectorsHealthcare
- Website precisiondxlab.com
- Social LinkedIn X
- Acquired by BelHealth Investment Partners (May 2014)
- Legal Name Precision Diagnostics
- Latest Funding Round$14.5M (USD), Debt – Venture
Apr 2015
- InvestorsMonroe Capital
& 1 more
- Employee Count358
- Acquired byBelHealth Investment Partners
(May 2014)
Products & Services of Precision Diagnostics
Precision Diagnostics offers a comprehensive portfolio of products and services, including VerifID, NextGen, UpNEXT, and DDI.
DNA matching solution for accurate urine specimen identification.
LC-MS/MS technology for reliable drug level detection.
Virtual waiting room for streamlined patient visits.
Platform for identifying drug-to-drug interactions.
Funding Insights of Precision Diagnostics
- Total Rounds 1
- Last Round Debt – Venture — $14.5M
- First Round $14.5M
(Apr 2015)
- Investors Count 1
All 1 funding rounds of Precision Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2015 | $14.5M | Debt – Venture | – | – |
2 investors in total: 2 institutional.
Investors in Precision Diagnostics
Precision Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Monroe Capital and BelHealth Investment Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private debt financing is offered via specialized funds. | 2004 | monroecap.com | Chicago, United States | |
Investment in healthcare businesses, focusing on services, products, and distribution. | belhealth.com |
Investor details for Precision Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Precision Diagnostics
47 people are tracked at Precision Diagnostics (18 in leadership, 29 in team); the tracked headcount is 358.
| Name | Role | Group |
|---|---|---|
Amadeo Pesce | Laboratory Director | Leadership |
Greg Ackerman | President And Chief Technology Officer | Leadership |
Richard Thomas | Chief Scientific Officer | Leadership |
Miguel Gallego | Chief Executive Officer | Leadership |
Cortney Hergenroeder | Vice President Of Sales | Leadership |
Colm Driscoll | CFO | Leadership |
Lindsey Nelson | Director Of Customer Success | Leadership |
Joshua Corbin | Director Of Clinical Operations | Leadership |
Janea Courtright | Senior Director, Controller | Leadership |
Drew Gillespie | Director Of Human Resources | Leadership |
Mike Dietz | Director Of Sales | Leadership |
Megan Demers | Director Of Sales Operations | Leadership |
Heather Kaufman | Chief Compliance Officer | Leadership |
Allison Emery | Director Of Learning & Development, Sales | Leadership |
Luann Merrill | Director Of Managed Care | Leadership |
James Keeley | Director Of Information Technology | Leadership |
Jennifer Allison | Chief Healthcare Operations Officer | Leadership |
Nicole Chandler | Vice President Ways Of Working | Leadership |
Grace Carmel | Senior Territory Manager | Team |
Marlee Morgan | Territory Manager | Team |
27 more people are available in the full profile.
Complete people profiles for Precision Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Precision Diagnostics
3 dated milestones of Precision Diagnostics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Precision Diagnostics is founded.
- Exit Acquired by BelHealth Investment Partners.
- Funding First funding round of $14.5M.
Competitors of Precision Diagnostics
Precision Diagnostics has 3 listed competitors in our database, 2 of them funded. They include IntegenX, Ameritox and Abreos Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| integenx.com | 2006 | Pleasanton, United States | $92.06M | 78 | Instruments for rapid human DNA identification are developed. | |
| ameritox.com | 1996 | Baltimore, United States | Pain medication monitoring solutions are provided for US clinicians. | |||
| abreos.com | 2013 | San Diego, United States | $725,000 | Developing point-of-care tests for personalized dosing and counterfeit detection of biologic drugs |
Detailed competitors of Precision Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Toxicology
3 companies that operate in the same segment as Precision Diagnostics (Toxicology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutic solutions for food allergies are developed via antibody platforms. | 2019 | San Francisco, California, United States | USD 75 M | |||
Therapeutics for substance use disorders, including opioid-related conditions, are developed. | 2020 | Oakland, California, United States | USD 70 M | |||
Drug delivery solutions via single-walled carbon nanotubes are offered. | 2008 | Houston, Texas, United States | USD 2.5 M | USD 5.07 M | 9 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Precision Diagnostics
Complete news archive for Precision Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Precision Diagnostics
Precision Diagnostics was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Precision Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Precision Diagnostics has 358 employees.
Precision Diagnostics, formerly known as Precision Toxicology, provides quantitative confirmation urine drug testing services that allow physicians to monitor patients on chronic opioid therapy. Its test panel technology tests for various prescription medications, as well as illicit drugs. Services include NextGen Precision Testing platform; Precision TBM, a Toxicology Benefit Management program to better manage the clinical drug testing benefit; SOF-Adhere , to detect the amount of the sofosbuvir metabolite in a patients urine sample and Oral fluid testing. It is a BelHealth portfolio company since April 2014.
Precision Diagnostics's top competitors include IntegenX, Ameritox and Abreos Biosciences.
Precision Diagnostics offers VerifID, NextGen, UpNEXT, and DDI.
Precision Diagnostics has 2 investors. Key investors include Monroe Capital, and BelHealth Investment Partners.
Precision Diagnostics operates through Precision Diagnostics.
Yes. Precision Diagnostics was acquired by BelHealth Investment Partners in May 2014.